Business
Mauna Kea Technologies and TaeWoong Medical USA Announce Exclusive Partnership to Accelerate Commercial Expansion in the U.S. in Pancreatic Cyst Management
LOS ANGELES & PARIS & BOSTON, December 03, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform and TaeWoong Medical USA, a leader in minimally invasive gastrointestinal (GI) diagnostic and therapeutic EUS guided solutions, today announced the signing of an exclusive partnership in the United States to bring physicians and hospitals the industry’s first fully in
About this update from Mauna Kea Technologies Sa Class O
[{"type":"text","content":"Integrating Cellvizio® into TaeWoong’s portfolio of therapeutic devices to create the first fully integrated "imaging-to-therapy" solution for EUS-guided pancreatic care","length":179,"tagName":"p","attribs":{}},{"type":"text","content":"LOS ANGELES & PARIS & BOSTON, December 03, 2025--(BUSINESS WIRE)--Regulatory News:","length":90,"tagName":"p"},{"type":"text","content":"Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform and TaeWoong Medical USA, a leader in minimally invasive gastrointestinal (GI) diagnostic and therapeutic EUS guided solutions, today announced the signing of an exclusive partnership in the United States to bring physicians and hospitals the industry’s first fully integrated "imaging-to-therapy" solution for pancreatic cystic lesions (PCLs) and related disorders.","length":542,"tagName":"p"},{"type":"text","content":"Uniting Cellvizio® needle-based, real-time cellular imaging solution with TaeWoong’s proven EUS-guided therapeutic capabilities will create a cohesive clinical program designed to streamline workflow, enhance clinical accuracy and elevate patient outcomes across pancreatic cyst diagnosis, risk stratification, and treatment, thereby better addressing one of the fastest-growing indications challenges in digestive oncology.","length":424,"tagName":"p"},{"type":"text","content":"The partnership integrates two highly complementary portfolios, enabling a streamlined and co-branded "Pancreatic Cyst Imaging and Management Program – Powered by Cellvizio®" with key features that include:","length":216,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Real-time cellular-level, nCLE imaging from Mauna Kea of pancreatic cysts during EUS procedures","length":95,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Advanced EUS-guided diagnostic and therapeutic instruments from TaeWoong Medical for treatment — combining diagnostic clarity and interventional capability in one streamlined workflow","length":183,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Clinical onboarding, training and ongoing support for physicians and care teams to adopt the integrated platform safely and effectively","length":135,"tagName":...